Home
>
National Drug Code (NDC)
>
CAPTOPRIL
CAPTOPRIL - 68788-9731-3 - (CAPTORPIL)
Drug Information of CAPTOPRIL
| Product NDC: | 68788-9731 |
| Proprietary Name: | CAPTOPRIL |
| Non Proprietary Name: | CAPTORPIL |
| Active Ingredient(s): | 25 mg/1 & nbsp; CAPTORPIL |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of CAPTOPRIL
| Product NDC: | 68788-9731 |
| Labeler Name: | Preferred Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074532 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121213 |
Package Information of CAPTOPRIL
| Package NDC: | 68788-9731-3 |
| Package Description: | 30 TABLET in 1 BOTTLE (68788-9731-3) |
NDC Information of CAPTOPRIL
| NDC Code | 68788-9731-3 |
| Proprietary Name | CAPTOPRIL |
| Package Description | 30 TABLET in 1 BOTTLE (68788-9731-3) |
| Product NDC | 68788-9731 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CAPTORPIL |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20121213 |
| Marketing Category Name | ANDA |
| Labeler Name | Preferred Pharmaceuticals, Inc. |
| Substance Name | CAPTOPRIL |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
